Notably, a significant difference in serological response seen when comparing CLL patients and the overall group of patients confirmed the state of immunosuppression of these patients, also highlighted by lower levels of circulating immunoglobulin, often below the minimum value (63.6% for IgA and IgG, 75% for IgM). This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.